Cargando…
Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study
AIMS: The cost of drug regimens prescribed to Chinese patients has not been evaluated. This study aims to evaluate the medical costs and hypoglycemic agents for diabetes mellitus patients with or without chronic respiratory disease in Beijing, and to investigate the changes in the costs and number o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458880/ https://www.ncbi.nlm.nih.gov/pubmed/36093107 http://dx.doi.org/10.3389/fendo.2022.980982 |
_version_ | 1784786375067828224 |
---|---|
author | Qiao, Jingtao Tan, Zheng Xu, Xiaomao Zhou, Yan Wang, Weihao Luo, Jingyi Fan, Jingwen Pan, Qi Guo, Lixin |
author_facet | Qiao, Jingtao Tan, Zheng Xu, Xiaomao Zhou, Yan Wang, Weihao Luo, Jingyi Fan, Jingwen Pan, Qi Guo, Lixin |
author_sort | Qiao, Jingtao |
collection | PubMed |
description | AIMS: The cost of drug regimens prescribed to Chinese patients has not been evaluated. This study aims to evaluate the medical costs and hypoglycemic agents for diabetes mellitus patients with or without chronic respiratory disease in Beijing, and to investigate the changes in the costs and number of antidiabetic medications used for diabetes patients with chronic respiratory disease from 2016 to 2018. METHODS: This observational, retrospective study included diabetes patients with outpatient medication records from Beijing Medical Insurance between 2016 and 2018. The medications, including hypoglycemic and nonhypoglycemic drugs, insulin dosage, comorbidities, diabetes-related complications, treatment strategies, and annual medical costs, were recorded. RESULTS: This study included 2,853,036 diabetes patients from 2016 to 2018. About 18.95%–20.53% of patients with chronic respiratory disease were predominantly distributed among those aged 45–84 years (88.7%–89.1%). Diabetes patients with chronic respiratory disease used more medications (4.48 ± 2.41 vs. 3.76 ± 2.33) and had higher total annual drug costs (¥12,286 ± 10,385 vs. ¥9700 ± 9202) to treat more comorbidities (2.52 ± 1.53 vs. 2.05 ± 1.85) than those without chronic respiratory disease (p <.0001, respectively). From 2016 to 2018, diabetes patients with chronic respiratory disease had a 4.2% increase in medication, a 1.9% decrease in comorbidities, and a 5.4% decrease in total annual drug costs. CONCLUSIONS: In summary, diabetes patients with chronic respiratory disease had more comorbidities, required more hypoglycemic drugs, and had higher medical costs. During 2016–2018, diabetes patients with chronic respiratory disease used more medications and spent less money on medical care. |
format | Online Article Text |
id | pubmed-9458880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94588802022-09-10 Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study Qiao, Jingtao Tan, Zheng Xu, Xiaomao Zhou, Yan Wang, Weihao Luo, Jingyi Fan, Jingwen Pan, Qi Guo, Lixin Front Endocrinol (Lausanne) Endocrinology AIMS: The cost of drug regimens prescribed to Chinese patients has not been evaluated. This study aims to evaluate the medical costs and hypoglycemic agents for diabetes mellitus patients with or without chronic respiratory disease in Beijing, and to investigate the changes in the costs and number of antidiabetic medications used for diabetes patients with chronic respiratory disease from 2016 to 2018. METHODS: This observational, retrospective study included diabetes patients with outpatient medication records from Beijing Medical Insurance between 2016 and 2018. The medications, including hypoglycemic and nonhypoglycemic drugs, insulin dosage, comorbidities, diabetes-related complications, treatment strategies, and annual medical costs, were recorded. RESULTS: This study included 2,853,036 diabetes patients from 2016 to 2018. About 18.95%–20.53% of patients with chronic respiratory disease were predominantly distributed among those aged 45–84 years (88.7%–89.1%). Diabetes patients with chronic respiratory disease used more medications (4.48 ± 2.41 vs. 3.76 ± 2.33) and had higher total annual drug costs (¥12,286 ± 10,385 vs. ¥9700 ± 9202) to treat more comorbidities (2.52 ± 1.53 vs. 2.05 ± 1.85) than those without chronic respiratory disease (p <.0001, respectively). From 2016 to 2018, diabetes patients with chronic respiratory disease had a 4.2% increase in medication, a 1.9% decrease in comorbidities, and a 5.4% decrease in total annual drug costs. CONCLUSIONS: In summary, diabetes patients with chronic respiratory disease had more comorbidities, required more hypoglycemic drugs, and had higher medical costs. During 2016–2018, diabetes patients with chronic respiratory disease used more medications and spent less money on medical care. Frontiers Media S.A. 2022-08-26 /pmc/articles/PMC9458880/ /pubmed/36093107 http://dx.doi.org/10.3389/fendo.2022.980982 Text en Copyright © 2022 Qiao, Tan, Xu, Zhou, Wang, Luo, Fan, Pan and Guo https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Qiao, Jingtao Tan, Zheng Xu, Xiaomao Zhou, Yan Wang, Weihao Luo, Jingyi Fan, Jingwen Pan, Qi Guo, Lixin Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study |
title | Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study |
title_full | Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study |
title_fullStr | Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study |
title_full_unstemmed | Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study |
title_short | Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study |
title_sort | medications and medical costs for diabetes patients with or without chronic respiratory disease in beijing, china: a retrospective study |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458880/ https://www.ncbi.nlm.nih.gov/pubmed/36093107 http://dx.doi.org/10.3389/fendo.2022.980982 |
work_keys_str_mv | AT qiaojingtao medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT tanzheng medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT xuxiaomao medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT zhouyan medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT wangweihao medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT luojingyi medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT fanjingwen medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT panqi medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy AT guolixin medicationsandmedicalcostsfordiabetespatientswithorwithoutchronicrespiratorydiseaseinbeijingchinaaretrospectivestudy |